These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
432 related articles for article (PubMed ID: 31324197)
1. IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma. Wu J; Gao FX; Wang C; Qin M; Han F; Xu T; Hu Z; Long Y; He XM; Deng X; Ren DL; Dai TY J Exp Clin Cancer Res; 2019 Jul; 38(1):321. PubMed ID: 31324197 [TBL] [Abstract][Full Text] [Related]
2. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway. Liu Y; Zhi Y; Song H; Zong M; Yi J; Mao G; Chen L; Huang G J Exp Clin Cancer Res; 2019 Aug; 38(1):369. PubMed ID: 31438989 [TBL] [Abstract][Full Text] [Related]
3. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma. Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144 [TBL] [Abstract][Full Text] [Related]
4. IL-8/CXCR2 Signalling Promotes Cell Proliferation in Oesophageal Squamous Cell Carcinoma and Correlates With Poor Prognosis. Inoue M; Takeuchi H; Matsuda S; Nishi T; Fukuda K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Kitagawa Y Anticancer Res; 2021 Feb; 41(2):783-794. PubMed ID: 33517283 [TBL] [Abstract][Full Text] [Related]
5. Liujunzi decoction exerts potent antitumor activity in oesophageal squamous cell carcinoma by inhibiting miR-34a/STAT3/IL-6R feedback loop, and modifies antitumor immunity. Han Y; Fan X; Fan L; Wu Y; Zhou Z; Wang G; Guo L; Gao W; Chen Y; Gao Q Phytomedicine; 2023 Mar; 111():154672. PubMed ID: 36701994 [TBL] [Abstract][Full Text] [Related]
6. Reciprocal androgen receptor/interleukin-6 crosstalk drives oesophageal carcinoma progression and contributes to patient prognosis. Dong H; Xu J; Li W; Gan J; Lin W; Ke J; Jiang J; Du L; Chen Y; Zhong X; Zhang D; Yeung SJ; Li X; Zhang H J Pathol; 2017 Mar; 241(4):448-462. PubMed ID: 27801498 [TBL] [Abstract][Full Text] [Related]
7. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway. Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway. Zhao Y; Ma K; Yang S; Zhang X; Wang F; Zhang X; Liu H; Fan Q Int J Oncol; 2018 Aug; 53(2):644-658. PubMed ID: 29767234 [TBL] [Abstract][Full Text] [Related]
9. Oesophageal squamous cell carcinoma-associated IL-33 rewires macrophage polarization towards M2 via activating ornithine decarboxylase. Mai S; Liu L; Jiang J; Ren P; Diao D; Wang H; Cai K Cell Prolif; 2021 Feb; 54(2):e12960. PubMed ID: 33305406 [TBL] [Abstract][Full Text] [Related]
10. IL-6-induced CD39 expression on tumor-infiltrating NK cells predicts poor prognosis in esophageal squamous cell carcinoma. Zheng Y; Li Y; Tang B; Zhao Q; Wang D; Liu Y; Guo M; Zhao S; Qi Y; Zhang Y; Huang L Cancer Immunol Immunother; 2020 Nov; 69(11):2371-2380. PubMed ID: 32524362 [TBL] [Abstract][Full Text] [Related]
11. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation. Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305 [TBL] [Abstract][Full Text] [Related]
12. STAT3-EphA7 axis contributes to the progression of esophageal squamous cell carcinoma. Wang L; Zhao QF; Yang BB; Liang HJ; Zhang XE; Zhang XY; Yang WJ; Guo ZY; Xu X; Tian F; Wu QH Acta Oncol; 2023 Dec; 62(12):1757-1766. PubMed ID: 37738252 [TBL] [Abstract][Full Text] [Related]
13. MiR-874-3p is an independent prognostic factor and functions as an anti-oncomir in esophageal squamous cell carcinoma via targeting STAT3. Yuan RB; Zhang SH; He Y; Zhang XY; Zhang YB Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7265-7273. PubMed ID: 30468470 [TBL] [Abstract][Full Text] [Related]
14. Capn4 promotes esophageal squamous cell carcinoma metastasis by regulating ZEB1 through the Wnt/β-catenin signaling pathway. Zhao YL; Li JB; Li YJ; Li SJ; Zhou SH; Xia H Thorac Cancer; 2019 Jan; 10(1):24-32. PubMed ID: 30444080 [TBL] [Abstract][Full Text] [Related]
15. Ivermectin suppresses tumour growth and metastasis through degradation of PAK1 in oesophageal squamous cell carcinoma. Chen L; Bi S; Wei Q; Zhao Z; Wang C; Xie S J Cell Mol Med; 2020 May; 24(9):5387-5401. PubMed ID: 32237037 [TBL] [Abstract][Full Text] [Related]
16. PBX1 Increases the Radiosensitivity of Oesophageal Squamous Cancer by Targeting of STAT3. Yu D; Ma Y; Feng C; Ma Z; Guo J; Chen H; He T; Guo J; Sun X; Qin Q; Sun X; Ma J Pathol Oncol Res; 2020 Oct; 26(4):2161-2168. PubMed ID: 32170580 [TBL] [Abstract][Full Text] [Related]
17. The natural polyphenol curcumin induces apoptosis by suppressing STAT3 signaling in esophageal squamous cell carcinoma. Liu Y; Wang X; Zeng S; Zhang X; Zhao J; Zhang X; Chen X; Yang W; Yang Y; Dong Z; Zhu J; Xu X; Tian F J Exp Clin Cancer Res; 2018 Dec; 37(1):303. PubMed ID: 30518397 [TBL] [Abstract][Full Text] [Related]
18. JAK2 inhibitor blocks the inflammation and growth of esophageal squamous cell carcinoma in vitro through the JAK/STAT3 pathway. Fang J; Chu L; Li C; Chen Y; Hu F; Zhang X; Zhao H; Liu Z; Xu Q Oncol Rep; 2015 Jan; 33(1):494-502. PubMed ID: 25405520 [TBL] [Abstract][Full Text] [Related]
19. NANOG Promotes Cell Proliferation, Invasion, and Stemness via IL-6/STAT3 Signaling in Esophageal Squamous Carcinoma. Deng L; Zhang X; Xiang X; Xiong R; Xiao D; Chen Z; Liu K; Feng G Technol Cancer Res Treat; 2021; 20():15330338211038492. PubMed ID: 34520294 [No Abstract] [Full Text] [Related]
20. The transcription factor LEF1 promotes tumorigenicity and activates the TGF-β signaling pathway in esophageal squamous cell carcinoma. Zhao Y; Zhu J; Shi B; Wang X; Lu Q; Li C; Chen H J Exp Clin Cancer Res; 2019 Jul; 38(1):304. PubMed ID: 31296250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]